Dr Sophie Laurenson, Project Lead
Apr 03, 2012.
Abbott Diagnostics presentation unavailable*
Abbott Diagnostics audio unavailable*
• An overview of the in vitro diagnostics (IVD) industry
• Products and markets within the IVD industry
• Opportunities for new technologies in diagnostics
Speaker Biography (Sophie Laurenson)
Sophie Laurenson is a Project Manager in the New Technology Group at Abbott Diagnostics. Originally trained as a biologist, she shifted focus to biophysics during her Doctoral studies and has worked in the biosensor and microfluidics fields for the past ten years in both academia and industry. Currently based in Basel, Switzerland, she is involved in technology discovery and diligence processes leading to the integration of emerging technologies into Abbott Diagnostics businesses.
Company Profile (Abbott Diagnostics)
Abbott is a Fortune 200 company founded in 1888 and headquarted at Abbott Park in the Northern Chicago suburbs. Abbott has become a global, broad-based health care company, distributing products in more than 130 countries and employing more than 70000 people worldwide. The Abbott portfolio contains products spanning the continuum of care, from nutritional products and laboratory diagnostics through medical devices and branded generic pharmaceutical therapies